Symptoms of SARS-CoV-2 patients in a second level hospital

Authors

  • Sara Lizbeth Montaño-Rosales <p>Instituto Mexicano del Seguro Social&nbsp;</p>
  • Eduardo Alberto García-Pulido <p>Instituto Mexicano del seguro Social,&nbsp;Hospital General de Zona No.1.Tepic, Nayarit. M&eacute;xico&nbsp;</p>
  • María Elena Rivera-Pérez <p>Instituto Mexicano del Seguro Social&nbsp;</p> http://orcid.org/0000-0002-8157-9100
  • Hasel Gabriel Virgen-Castillo <p>Instiuto Mexicano del Seguro Social&nbsp;</p> http://orcid.org/0000-0003-2729-5497
  • Víctor Ramón Alcantar-Vázquez <p>Instituto Mexicano del Seguro Social&nbsp;</p>
  • Aidé Tirado-García <p>Instituto Mexicano del Seguro Social&nbsp;</p>
  • Ernesto Jiménez-Arredondo <p>Instituto Mexicano del Seguro Social&nbsp;</p> http://orcid.org/0000-0003-1240-0645
  • Esaú Rojas-Carrillo <p>Instituto Mexicano del Seguro Social&nbsp;</p> http://orcid.org/0000-0003-2729-5497
  • Luisa Elizabeth Velasco-González <p>Instituto Mexicano del Seguro Social&nbsp;</p> http://orcid.org/0000-0002-3792-1538

DOI:

https://doi.org/10.24875/

Keywords:

Coronavirus Infections, Respiratory Tract Diseases, Pandemics

Abstract

Introduction: T he COVID-19 p andemic caused by t he SARS-CoV-2 coronavirus h as shaken the
world since the beginning of 2020, causing a huge number of patient deaths.
Objective: To evaluate the main symptoms of patients hospitalized for SARS CoV-2 in th e H.G.Z
No.1 of the IMSS in Nayarit.
Methodology: It is a retrospective, observational and cross-sectional study, with information
collected from the clinical records of patients admitted through the respiratory triage area with
a diagnosis of SARS Cov-2, confirmed with PCR.
Results: 433 patients were included, of these 267 male patients (62%) and 166 female patients
(38%), with an average age of 62 years. Within the main symptomatology is dyspnea (96%), fever
(78%), attack to the general state (78%), cough (76%) and headache (67%). In addition, 102 (23.6%)
patients required advanced airway management, of whom 89 died (87%). Of the total number of
patients, 208 (48%) died and 225 (54%) showed improvement.
Conclusions: The main symptoms of patients hospitalized for SARS CoV-2 are dyspnea, fever, general
condition attack, cough and headache.

References

 

  1. Ramirez S.C. Los profesionales de la salud en los tiempos de la pandemia: personal de Enfermería frente al COVID-19. Rev Enferm Inst Mex Seguro Soc. 2020;28(1):1-4.

  2. Organización Mundial de la Salud. COVID-19: cronología de la actuación de la OMS. Ginebra: OMS; 2020. Disponible en: https://www.who.int/es/news/item/27-04-2020-who-timeline---covid-19

  3. Meléndez A, Segovia M, Cova S, Hernández M, Martínez A, Magallanes A, Zarrelli R, Rísquez A, Andonaegui L. Características y evolución clínico-epidemiológica según su gravedad en pacientes ingresados con la COVID 19 confirmado. Bol Venez Infectol. 2021; 32 (1):27-42. 

  4. Escudero X, Guarner J, Galindo A, Escudero M, Alcocer M, Del Rio C. La pandemia de coronavirus SARS‑CoV-2 (COVID‑19): situación actual e implicaciones para México. Cardiovasc Metab Sci. 2020; 31 (3):170-177. DOI: 10.24875/ACM.M20000064

  5. Gobierno del Estado de Nayarit. 2020. Disponible en: https://covid19.nayarit.gob.mx

  6. Organización Mundial de la Salud. Manejo Clínico de la COVID-19. OMS: Ginebra; 2021. Disponible con: https://www.who.int/es/publications/i/item/WHO-2019-nCoV-clinical-2021-1

  7. Quesada J.A, López A, Gil V.F, Arriero J.M, Gutiérrez F, Carratala C. Incubation period of COVID-19: A systematic review and meta-analysis. Rev Clin Esp (Barc). 2021; 221(2):109-117. DOI: 10.1016/j.rce.2020.08.005

  8. Ministerio de Sanidad. Enfermedad por coronavirus, COVID-19. España: Centro de Coordinación de Alertas y Emergencias Sanitarias; 2021. 

  9. Struyf T, Deeks J.J, Dinnes J, Takwoingi Y, Davenport C, Leeflang M.M.G, Spijker R, Hooft L, Emperador D, Domen J, Horn SR A, Van den Bruel A. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19. Cochrane Database of Systematic Reviews. 2021; Issue 2. Art. No.: CD013665. DOI: 10.1002/14651858.CD013665.pub2.

  10. Solano M.A, Coronado A.R, Velásquez A.L, Salazar J, Sánchez S, Luria D.J, Ordaz W.A, Salazar I.R, Jiménez G.E. Factores de riesgo asociados a la mortalidad en pacientes con COVID-19, en el estado de Oaxaca. Avan C Salud Med. 2020; 7(4): 99-110.  

  11. Alimohamadi Y. Sepandi M. Rashti R. Sedighinezhad H. Afrashteh S. COVID-19: Clinical features, case fatality, and the effect of symptoms on mortality in hospitalized cases in Iran. J Taibah Univ Med Sci. 2022;17(5):725-731. DOI: 10.1016/j.jtumed.2022.04.010.

  12. Gemmati D. Bramanti B. Serino M.L. Secchiero P. Zauli G. Tisato V. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Int J Mol Sci. 2020;21(10):3474. DOI: 10.3390/ijms21103474. 

  13. Macedo M.C.F, Pinheiro I.M, Carvalho C.J.L, Fraga H.C.J.R, Araujo I.P.C, Montes S.S, Araujo O.A.C, Alves L.A, Saba H, Araújo M.L.V, Queiroz I.T.L, Sampaio R.L, Souza M.S.P.L, Da Silva A.C.F.N, Souza A.C.S. Correlation between hospitalized patients' demographics, symptoms, comorbidities, and COVID-19 pandemic in Bahia, Brazil. PLoS One. 2020; 14;15(12):e0243966. DOI: 10.1371/journal.pone.0243966.

  14. Instituto Nacional de Geriatría. Covid-19: prevención y cuidados en personas mayores. México: Secretaría de Salud. 2020. 

  15. Águila D, Martínez J, Mazoteras V, Negreira M, Nieto P, Piqueras J. Mortality and associated prognostic factors in elderly and very elderly hospitalized patients with respiratory disease COVID-19. Rev Esp Geriatr Gerontol. 2021; 56(5):259-267. DOI: 10.1016/j.regg.2020.09.006

  16. Norooznezhad A.H, Najafi F, Riahi P, Moradinazar M, Shakiba E, Mostafaei S. Primary Symptoms, Comorbidities, and Outcomes of 431 Hospitalized Patients with Confirmative RT-PCR Results for COVID-19. Am J Trop Med Hyg. 2020 Aug;103(2):834-837. DOI: 10.4269/ajtmh.20-0512.

  17. Telecomunicaciones de México. Guía Clínica para el tratamiento de la Covid-19 en México. México: Gobierno de México; 2021. 

  18. Yupari I, Bardales L, Rodríguez J, Barros J.S, Rodríguez A. Factores de riesgo de mortalidad por Covid-19 en pacientes hospitalizados: un modelo de regresión logística. Rev. Fac. Med. 2021; 21 (1): 19-27. DOI: 10.25176/RFMH.v21i1.3264

  19.  Gil R, Bitar P, Deza C, Dreyse J, Florenzano M, Ibarra C, Jorquera J, Melo J, Olivi H, Parada M.T, Rodríguez J.C, Undurraga A. Cuadro Clínico del COVID-19. Rev. Med. Clin. Condes. 2021; 32(1): 20-29. DOI: 10.1016/j.rmclc.2020.11.004

  20.  Li X, Tian J, Xu Q. The Associated Factors of Anxiety and Depressive Symptoms in COVID-19 Patients Hospitalized in Wuhan, China. Psychiatr Q. 2021 Sep;92(3):879-887. DOI: 10.1007/s11126-020-09865-9.

  21. Peramo F.P, López M.A, López M.A. Secuelas médicas de la Covid-19. Medicina clínica. 2021; 157(8), 388–394. DOI: 10.1016/j.medcli.2021.04.023

  22. Gobierno de México. Guía Clínica para el tratamiento de la COVID-19 en México. México: Consenso interinstitucional; 2021.

  23. Ronco C, Reis T, Husain F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020; 8(7):738-742. DOI: 10.1016/S2213-2600(20)30229-0

  24. Roghani A. The Influence of COVID-19 Vaccination on Daily Cases, Hospitalization, and Death Rate in Tennessee, United States: Case Study. JMIRx Med. 2021; 12; 2(3): e29324. DOI: 10.2196/29324

Downloads

Published

2023-10-03

Issue

Vol. 31 No. 4 (2023): Octubre - diciembre

Section

Investigación

License

Copyright (c) 2023 Revista de Enfermería del Instituto Mexicano del Seguro Social

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.